This study sought to assess the effect of common CHIP mutations on cardiovascular health and survival outcomes in a patient cohort comprising exclusively of individuals diagnosed with cancer, and to examine the clinical significance of co-occurring CHIP and mCAs on these outcomes. The gene discussed is STUB1; the disease is cancer.